84 related articles for article (PubMed ID: 28378635)
1. Methylation of the UNC5C gene and its protein expression in colorectal cancer.
Wu J; Wang G; He B; Chen X; An Y
Tumour Biol; 2017 Apr; 39(4):1010428317697564. PubMed ID: 28378635
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer.
Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Sanada Y
World J Surg; 2009 May; 33(5):1053-7. PubMed ID: 19242752
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies.
Bernet A; Mazelin L; Coissieux MM; Gadot N; Ackerman SL; Scoazec JY; Mehlen P
Gastroenterology; 2007 Dec; 133(6):1840-8. PubMed ID: 17967459
[TBL] [Abstract][Full Text] [Related]
5. Changes in UNC5C gene methylation during human gastric carcinogenesis.
Hibi K; Sakata M; Sakuraba K; Kitamura YH; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2009 Nov; 29(11):4397-9. PubMed ID: 20032384
[TBL] [Abstract][Full Text] [Related]
6. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.
Shin SK; Nagasaka T; Jung BH; Matsubara N; Kim WH; Carethers JM; Boland CR; Goel A
Gastroenterology; 2007 Dec; 133(6):1849-57. PubMed ID: 18054557
[TBL] [Abstract][Full Text] [Related]
8. Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.
Mur P; Sánchez-Cuartielles E; Aussó S; Aiza G; Valdés-Mas R; Pineda M; Navarro M; Brunet J; Urioste M; Lázaro C; Moreno V; Capellá G; Puente XS; Valle L
Sci Rep; 2016 Feb; 6():20697. PubMed ID: 26852919
[TBL] [Abstract][Full Text] [Related]
9. Significant Pattern of Promoter Hypermethylation of UNC5C Gene in Colorectal Cancer and Its Implication in Late Stage Disease.
Guroo SA; Malik AA; Afroze D; Ali S; Pandith AA; Yusuf A
Asian Pac J Cancer Prev; 2018 May; 19(5):1185-1188. PubMed ID: 29801399
[TBL] [Abstract][Full Text] [Related]
10. MGMT gene is aberrantly methylated from the early stages of colorectal cancers.
Hibi K; Goto T; Mizukami H; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Hepatogastroenterology; 2009; 56(96):1642-4. PubMed ID: 20214209
[TBL] [Abstract][Full Text] [Related]
11. Methylation of the UNC5C gene is frequently detected in hepatocellular carcinoma.
Hibi K; Sakuraba K; Shirahata A; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Hepatogastroenterology; 2012; 59(120):2573-5. PubMed ID: 23178624
[TBL] [Abstract][Full Text] [Related]
12. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
Dong D; Zhang R; Shao J; Zhang A; Wang Y; Zhou Y; Li Y
Clin Epigenetics; 2021 Dec; 13(1):225. PubMed ID: 34922605
[TBL] [Abstract][Full Text] [Related]
15. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
[TBL] [Abstract][Full Text] [Related]
16. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
[TBL] [Abstract][Full Text] [Related]
17. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
19. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
